What is Dravet Syndrome?

Dravet syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare form of intractable epilepsy that begins in infancy and proceeds with accumulating morbidity that significantly impacts individuals throughout their lifetime. It has an estimated incidence rate of 1:15,700. [1]

Community. Research. Progress.

Raising Hope & Changing Lives through Research

The mission of Dravet Syndrome Foundation (DSF) is to aggressively raise funds for Dravet syndrome and related epilepsies; to support and fund research; increase awareness; and to provide support to affected individuals and families.

We know that the fight against Dravet syndrome will never be successful without teamwork. None of us can do this alone and to achieve great things we must work together.

Thanks to the collective efforts of our community, DSF has achieved numerous milestones to celebrate. Become a part of #TeamDSF by donating, launching a personal fundraising campaign, or exploring other ways to give.

DSF Recent News & Information

Keep up to date on current information that is important to you in our weekly Decoding Dravet Blog posts and through our email updates.  

AES 2025: Big Moments and Emerging Insights for Dravet Syndrome

Dravet Syndrome Foundation attended the 2025 American Epilepsy Society (AES) Annual Meeting in Atlanta on December 5th -9th, where we participated and engaged in educational ...
Read More →

Announcing DSF’s 2025 Grant Awards

Dravet Syndrome Foundation (DSF) announced our 2025 Grant Awards last night at the 16th Annual Research Roundtable for eight outstanding projects totaling $1.725M. The addition ...
Read More →

Cell-type resolved molecular and functional pathology in Scn1a mutant mouse cerebellum

Alex Nord, PhD- University of California DavisDiasynou Fioravante, PhD- University of California Davis Cell-type resolved molecular and functional pathology in Scn1a mutant mouse cerebellumResearch Grant- ...
Read More →
Scroll to Top